Durvalumab

Durvalumab is a specialised medicine used to treat certain advanced cancers, including non-small cell lung cancer, small cell lung cancer, and biliary tract cancer. It is prescribed to help slow down the spread of cancer cells and improve overall survival rates. Your doctor will determine if this therapy is the right choice for your specific diagnosis. Before starting treatment, your doctor may order a tumour biomarker test called PD-L1 testing to determine whether Durvalumab is suitable for your type of cancer. Not all patients need this test, and the requirement depends on the specific cancer and treatment setting.

This medicine is given as an intravenous infusion directly into a vein in a clinical setting, typically every 2 to 4 weeks. Consistency is key, so keeping all your scheduled appointments is vital for the treatment to be effective. Staying well-hydrated and consuming nutrient-rich, easy-to-digest foods can support your body during this therapy.

While taking Durvalumab, some patients may experience mild side effects like tiredness, mild skin rashes, or nausea. However, because this medicine affects the immune system, it can sometimes cause severe inflammation in healthy organs. You must contact your doctor immediately if you experience severe diarrhea, a new or worsening cough, or yellowing of your skin.

Do not take this if you have had a severe allergic reaction to Durvalumab or similar medications in the past. Before starting, tell your doctor if you have a history of liver damage, lung problems, autoimmune diseases, or an organ transplant. This medicine is not recommended for pregnant women as it can harm an unborn baby.

Certain medicines, especially strong steroids that suppress the immune system, can interact with Durvalumab and reduce its effectiveness. It is also important to avoid smoking and limit alcohol, as these can put extra strain on your lungs and liver. If you are breastfeeding or elderly, talk to your doctor or pharmacist about the specific risks and benefits of this treatment.

Using Durvalumab as prescribed helps your immune system recognise and fight cancer cells, slowing disease progression and supporting long-term cancer management. Here are the key benefits you can expect:

• Slows tumour growth: Helps slow the growth and spread of cancer cells, increasing the time the disease remains stable and allowing you to maintain your daily activities.
• Relieves cancer-related symptoms: Helps manage symptoms such as shortness of breath and chest pain by preventing tumours from growing further.
• Supports targeted cancer treatment: Works with your body's immune system to target cancer cells, providing a more focused treatment approach when used alone or in combination with chemotherapy.

• Follow your doctor’s instructions on the dosage and timing of this medication.
• Durvalumab is administered by the doctor or nurse.
• Do not self-administer.

Common Side Effects (Usually mild):

• Feeling very tired or weak
• Mild cough or shortness of breath
• Nausea or decreased appetite
• Mild skin rash or itching
• Constipation or mild diarrhea
   

Serious Side Effects (Consult your doctor right away):

• Signs of lung inflammation (new or worsening cough, difficulty breathing, chest pain)
• Signs of liver damage (yellowing of eyes or skin, dark urine, severe stomach pain)
• Severe bowel issues (severe watery or bloody diarrhea, severe stomach cramps)
• Signs of hormone problems (extreme fatigue, unexplained weight changes, feeling unusually hot or cold)
• igns of a severe allergic reaction (fever, chills, flushing, dizziness, or trouble breathing during infusion)